ViiV Healthcare receives European Commission approval for Apretude

cafead

Administrator
Staff member
  • cafead   Sep 20, 2023 at 08:42: AM
via ViiV Healthcare has received authorisation from the European Commission for Apretude (cabotegravir long-acting (LA) injectable and tablets) to prevent HIV.

article source